We are live on ! Find out more
ORPH

Orphazyme A/S

Delisted

ORPH was delisted on the 30th of March, 2022.

9 hedge funds and large institutions have $2.42M invested in Orphazyme A/S in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more funds holding

Funds holding: 59 (+4)

31% more capital invested

Capital invested by funds: $1.84M → $2.42M (+$579K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
4
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.12M +$1.64M +133,541 New
Millennium Management
2
Millennium Management
New York
$1.02M -$141K -11,422 -9%
CCM
3
CAAS Capital Management
New York
$169K -$59.6K -4,844 -19%
Osaic Holdings
4
Osaic Holdings
Arizona
$48K
PHK
5
Point72 Hong Kong
Hong Kong
$40K +$59.3K +4,817 New
Bank of America
6
Bank of America
North Carolina
$19K -$49.3K -4,001 -63%
CSS
7
Cubist Systematic Strategies
Connecticut
$4K +$6.03K +490 New
UBS Group
8
UBS Group
Switzerland
$3K -$24.8K -2,016 -87%
TRCT
9
Tower Research Capital (TRC)
New York
+$640 +52 New